๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Haematological Malignancy

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy NCT05646576NA1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Palliative Care, Usual Care A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma NCT07075328Phase 1, Phase 25 sites๐Ÿ“ Fukuoka๐Ÿ“ Sapporo๐Ÿ“ Kagoshima Otsuka Medical Devices Co., Ltd. Japan ยท Tests: Drug:5-ALA, Device:Photodynamic system Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors NCT06829654NA1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: Step 1, Step 2, Step 3, Step 4 Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: TruSight Oncology, imatinib A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product NCT05768269n/a7 sites๐Ÿ“ Gilbert๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Century Therapeutics, Inc. ยท Tests: No Intervention Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma NCT04234022n/a1 site๐Ÿ“ Wolverhampton The Royal Wolverhampton Hospitals NHS Trust ยท Tests: Zn-DDC, Lanalidomide with Zn-DDC, Pomalidomide with Zn-DDC Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment NCT07036133Phase 14 sites๐Ÿ“ Cerritos๐Ÿ“ Chicago๐Ÿ“ Detroit Acrotech Biopharma Inc. ยท Tests: Pralatrexate Injection A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy NCT06756321EARLY Phase 11 site๐Ÿ“ Nantong Affiliated Hospital of Nantong University ยท Tests: anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells, Fludarabine, Cyclophosphamide Prehabilitation for Patients Diagnosed With Blood Cancer and Treated With Al-logeneic Hematopoietic Stem Cell Transplantation NCT07341698NA1 site๐Ÿ“ Copenhagen Copenhagen University Hospital, Rigshospitalet ยท Tests: Resistance training, Nutritional Support, Usual care Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy NCT06895538Phase 2, Phase 31 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG) Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years NCT06455592NA1 site๐Ÿ“ Clermont-Ferrand University Hospital, Clermont-Ferrand ยท Tests: practice adapted physical activity, control arm Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation NCT06028828Phase 21 site๐Ÿ“ Orange University of California, Irvine ยท Tests: Fludarabine, Melphalan, Total Body Irradiation Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0) NCT07472972n/a1 site๐Ÿ“ Zurich University of Zurich Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease NCT06910969NA2 sites๐Ÿ“ Miami๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: HORIZONS Intervention, Minimally enhanced usual care A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) NCT07064122Phase 121 sites๐Ÿ“ Miami๐Ÿ“ Tampa๐Ÿ“ Houston AstraZeneca ยท Tests: AZD2962 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Phoenix Center for International Blood and Marrow Transplant Researโ€ฆ ยท Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Alectinib Halt Aging in Survivors of Blood Cancers NCT07292272NA1 site๐Ÿ“ Omaha University of Nebraska ยท Tests: Behavioral Coaching Intervention, Virtual Exercise Platform Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT NCT07511127Phase 31 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Maribavir MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms NCT07863466n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies NCT06066203Phase 1, Phase 21 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-035 Assessing DCog Short for Neurotoxicity in CAR-T NCT07403812NA1 site๐Ÿ“ Boston Beth Israel Deaconess Medical Center ยท Tests: DCog Short A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPฮฑ-CD47 Pathway, in Solid or Hematological Tumors NCT05892718Phase 18 sites๐Ÿ“ Port Saint Lucie๐Ÿ“ Huntersville๐Ÿ“ Greenville FBD Biologics Limited ยท Tests: HCB101 Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease NCT03844360Phase 42 sites๐Ÿ“ Xuzhou๐Ÿ“ Tanjin Wei Zhao ยท Tests: Bortezomib, Eltrombopag, Imatinib, dasatinib, Pegaspargase SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies NCT07153068Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: supCD7 CART cells International Leukemia Target Board NCT05270096n/a7 sites๐Ÿ“ Ghent๐Ÿ“ Copenhagen๐Ÿ“ Budapest Princess Maxima Center for Pediatric Oncology ยท Tests: Advice
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy